English 日本語

#ClinicalTrial

List of IR information related to "ClinicalTrial".

2 IR Posts
1 Companies
6 days ago Last Updated

Filters

Reset
Period:
Importance:
2 IR Posts
4502 Takeda Pharmaceutical Company Limited
2026/03/30
Announcement of Clinical Trial Results Suggesting Rapid and Sustained Improvement of Skin Symptoms with Zasocitinib, an Oral Drug with Once-Daily Dosing Convenience, and Its Potential to Transform Psoriasis Treatment

In the Phase 3 clinical trials of Zasocitinib, approximately 70% of patients achieved complete or near-complete clearance of skin symptoms at 16 weeks. Safety was consistent with previous trials with no new safety signals identified. Submission to the FDA in the United States is planned for fiscal 2026.

#TakedaPharmaceuticalCompany #NewDrugAnnouncement #Zasocitinib
4502 Takeda Pharmaceutical Company Limited
2026/01/20
(Correction) Partial correction regarding “Zasositinib for Plaque Psoriasis, Oral Once Daily Administration Shows Improvement in Skin Lesions and Possibility to Open a New Era of Treatment: Breakthrough Phase 3 Clinical Trial Data”

In the Phase 3 clinical trial of Zasositinib, the primary endpoints were achieved at week 16, with more than half of patients reaching PASI 90 and approximately 30% achieving PASI 100 indicating complete clearance of skin lesions. Safety profile was favorable.

#TakedaPharmaceuticalCompanyLimited #product_announcement #Zasositinib
Scroll to Top